# A Study In Patients With Type 2 Diabetes Mellitus

> **NCT00256867** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 369 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK523338

## Key facts

- **NCT ID:** NCT00256867
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08-18
- **Primary completion:** 2006-10-31
- **Final completion:** 2006-10-31
- **Target enrollment:** 369 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256867, "A Study In Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00256867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*